Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy (Review)
- Authors:
- Zhonghua Lu
- Yiting Tang
- Judong Luo
- Shuyu Zhang
- Xifa Zhou
- Lei Fu
-
Affiliations: Department of Radiation Oncology, Changzhou Cancer Hospital, Soochow University, Changzhou, Jiangsu 213001, P.R. China, Department of Radiation Biology, School of Radiation Medicine and Protection and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou, Jiangsu 215123, P.R. China, Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong 250117, P.R. China - Published online on: September 18, 2017 https://doi.org/10.3892/ol.2017.6991
- Pages: 5681-5687
This article is mentioned in:
Abstract
 |
 |
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, et al: Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials. Lancet Oncol. 16:630–637. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Adamowicz K and Goszczynska-Matysiak E: Combining systemic therapies with radiation in non small cell lung cancer. Klin Onkol. 28:321–331. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et al: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 327:1618–1624. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Warde P and Payne D: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol. 10:890–895. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Wan L, Pantel K and Kang Y: Tumor metastasis: Moving new biological insights into the clinic. Nat Med. 19:1450–1464. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ma Y, Yang Y, Wang F, Wei Q and Qin H: Hippo-YAP signaling pathway: A new paradigm for cancer therapy. Int J Cancer. 137:2275–2286. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gazdar AF: Epidermal growth factor receptor inhibition in lung cancer: The evolving role of individualized therapy. Cancer Metastasis Rev. 29:37–48. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Tang Y, Geng Y, Luo J, Shen W, Zhu W, Meng C, Li M, Zhou X, Zhang S and Cao J: Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo. Sci Rep. 5:94762015. View Article : Google Scholar : PubMed/NCBI | |
|
Sridhar SS, Seymour L and Shepherd FA: Inhibitors of epidermal-growth-factor receptors: A review of clinical research with a focus on non-small-cell lung cancer. Lancet Oncol. 4:397–406. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Hirsch FR, Varella-Garcia M, Cappuzzo F, McCoy J, Bemis L, Xavier AC, Dziadziuszko R, Gumerlock P, Chansky K, West H, et al: Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. Ann Oncol. 18:752–760. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Takahashi Y, Sakaguchi K, Horio H, Hiramatsu K, Moriya S, Takahashi K and Kawakita M: Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer. Br J Cancer. 113:1493–1501. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yoon HI, Park KH, Lee EJ, Keum KC, Lee CG, Kim CH and Kim YB: Overexpression of SOX-2 is associated with better overall survival in squamous cell lung cancer patients treated with adjuvant radiotherapy. Cancer Res Treat. 48:473–482. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Anscher MS, Chen L, Rabbani Z, Kang S, Larrier N, Huang H, Samulski TV, Dewhirst MW, Brizel DM, Folz RJ and Vujaskovic Z: Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy. Int J Radiat Oncol Biol Phys. 62:255–259. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Blahna MT and Hata A: Smad-mediated regulation of microRNA biosynthesis. FEBS Lett. 586:1906–1912. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Passaretti F, Tia M, D'Esposito V, De Pascale M, Del Corso M, Sepulveres R, Liguoro D, Valentino R, Beguinot F, Formisano P and Sammartino G: Growth-promoting action and growth factor release by different platelet derivatives. Platelets. 25:252–256. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ashcroft GS: Bidirectional regulation of macrophage function by TGF-beta. Microbes Infect. 1:1275–1282. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Boyd FT and Massagué J: Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J Biol Chem. 264:2272–2278. 1989.PubMed/NCBI | |
|
Hakenjos L, Bamberg M and Rodemann HP: TGF-beta1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol. 76:503–509. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Fajardo LF, Prionas SD, Kwan HH, Kowalski J and Allison AC: Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern. Lab Invest. 74:600–608. 1996.PubMed/NCBI | |
|
Phillips GD, Whitehead RA, Stone AM, Ruebel MW, Goodkin ML and Knighton DR: Transforming growth factor beta (TGF-B) stimulation of angiogenesis: An electron microscopic study. J Submicrosc Cytol Pathol. 25:149–155. 1993.PubMed/NCBI | |
|
Roberts AB, McCune BK and Sporn MB: TGF-beta: Regulation of extracellular matrix. Kidney Int. 41:557–559. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Heldin CH and Moustakas A: Role of Smads in TGFβ signaling. Cell Tissue Res. 347:21–36. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Santos JI, Teixeira AL, Dias F, Gomes M, Nogueira A, Assis J and Medeiros R: Restoring TGFβ1 pathway-related microRNAs: Possible impact in metastatic prostate cancer development. Tumor Biol. 35:6245–6253. 2014. View Article : Google Scholar | |
|
Bierie B and Moses HL: Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev. 21:49–59. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Connolly EC, Freimuth J and Akhurst RJ: Complexities of TGF-β targeted cancer therapy. Int J Biol Sci. 8:964–978. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Massagué J and Gomis RR: The logic of TGFbeta signaling. FEBS Lett. 580:2811–2820. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Koh PK, Faivre-Finn C, Blackhall FH and De Ruysscher D: Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapy. Cancer Treat Rev. 38:626–640. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rube CE, Palm J, Erren M, Fleckenstein J, König J, Remberger K and Rübe C: Cytokine plasma levels: Reliable predictors for radiation pneumonitis? PLoS One. 3:e28982008. View Article : Google Scholar : PubMed/NCBI | |
|
Anscher MS, Crocker IR and Jirtle RL: Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res. 122:77–85. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang XJ, Sun JG, Sun J, Ming H, Wang XX, Wu L and Chen ZT: Prediction of radiation pneumonitis in lung cancer patients: A systematic review. J Cancer Res Clin Oncol. 138:2103–2116. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Anscher MS, Marks LB, Shafman TD, Clough R, Huang H, Tisch A, Munley M, Herndon JE, Garst J, Crawford J and Jirtle RL: Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy. Int J Radiat Oncol Biol Phys. 56:988–995. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Novakova-Jiresova A, Van Gameren MM, Coppes RP, Kampinga HH and Groen HJ: Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol. 71:183–189. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Brizel DM, Rabbani ZN, Samulski TV, Farrell CL, Larrier N, Anscher MS and Vujaskovic Z: The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats. Int J Radiat Oncol Biol Phys. 60:1520–1529. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Portess DI, Bauer G, Hill MA and O'Neill P: Low-dose irradiation of nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis. Cancer Res. 67:1246–1253. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
De Jaeger K, Seppenwoolde Y, Kampinga HH, Boersma LJ, Belderbos JS and Lebesque JV: Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 58:1378–1387. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Anscher MS, Kong FM, Andrews K, Clough R, Marks LB, Bentel G and Jirtle RL: Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 41:1029–1035. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Anscher MS, Marks LB, Shafman TD, Clough R, Huang H, Tisch A, Munley M, Herndon JE II, Garst J, Crawford J and Jirtle RL: Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol. 19:3758–3765. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Qiao XY, Lu FH, Zhou ZG, Song YZ, Huo JJ and Liu X: TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy. Chin J Cancer. 29:325–329. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Z, Ma Y, Zhang S, Liu F, Wan M and Luo J: Transforming growth factor-β1 small interfering RNA inhibits growth of human embryonic lung fibroblast HFL-I cells in vitro and defends against radiation-induced lung injury in vivo. Mol Med Rep. 11:2055–2061. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Barthelemy-Brichant N, David JL, Bosquée L, Bury T, Seidel L, Albert A, Bartsch P, Baugnet-Mahieu L and Deneufbourg JM: Increased TGFbeta1 plasma level in patients with lung cancer: Potential mechanisms. Eur J Clin Invest. 32:193–198. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Dennis PA and Rifkin DB: Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA. 88:580–584. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Tredget EE and Ghahary A: Activation of latent transforming growth factor-beta1 is induced by mannose 6-phosphate/insulin-like growth factor-II receptor. Wound Repair Regen. 8:538–546. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Kong FM, Anscher MS, Sporn TA, Washington MK, Clough R, Barcellos-Hoff MH and Jirtle RL: Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 49:35–41. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Riley PA: Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 65:27–33. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Barcellos-Hoff MH and Dix TA: Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol. 10:1077–1083. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Kang SK, Rabbani ZN, Folz RJ, Golson ML, Huang H, Yu D, Samulski TS, Dewhirst MW, Anscher MS and Vujaskovic Z: Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 57:1056–1066. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Vujaskovic Z, Batinic-Haberle I, Rabbani ZN, Feng QF, Kang SK, Spasojevic I, Samulski TV, Fridovich I, Dewhirst MW and Anscher MS: A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med. 33:857–863. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Anscher MS, Kong FM, Marks LB, Bentel GC and Jirtle RL: Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys. 37:253–258. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Barthelemy-Brichant N, Bosquée L, Cataldo D, Corhay JL, Gustin M, Seidel L, Thiry A, Ghaye B, Nizet M, Albert A, et al: Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys. 58:758–767. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, Wang XS, Martel M, Komaki R, Cox JD, et al: Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol. 27:3370–3378. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao L, Ji W, Zhang L, Ou G, Feng Q, Zhou Z, Lei M, Yang W and Wang L: Changes of circulating transforming growth factor-beta1 level during radiation therapy are correlated with the prognosis of locally advanced non-small cell lung cancer. J Thorac Oncol. 5:521–525. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Carl C, Flindt A, Hartmann J, Dahlke M, Rades D, Dunst J, Lehnert H, Gieseler F and Ungefroren H: Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway. Cell Mol Life Sci. 73:427–443. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kelsey CR, Jackson L, Langdon S, Owzar K, Hubbs J, Vujaskovic Z, Das S and Marks LB: A polymorphism within the promoter of the TGFβ1 gene is associated with radiation sensitivity using an objective radiologic endpoint. Int J Radiat Oncol Biol Phys. 82:e247–e255. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bouquet F, Pal A, Pilones KA, Demaria S, Hann B, Akhurst RJ, Babb JS, Lonning SM, DeWyngaert JK, Formenti SC and Barcellos-Hoff MH: TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin Cancer Res. 17:6754–6765. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Guz M, Rivero-Müller A, Okoń E, Stenzel-Bembenek A, Polberg K, Słomka M and Stepulak A: MicroRNAs-role in lung cancer. Dis Markers. 2014:2181692014. View Article : Google Scholar : PubMed/NCBI | |
|
Chan SH and Wang LH: Regulation of cancer metastasis by microRNAs. J Biomed Sci. 22:92015. View Article : Google Scholar : PubMed/NCBI | |
|
Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, Moody SE, Chodosh LA and Arteaga CL: Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res. 64:9002–9011. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Muraoka RS, Dumont N, Ritter CA, Dugger TC, Brantley DM, Chen J, Easterly E, Roebuck LR, Ryan S, Gotwals PJ, et al: Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest. 109:1551–1559. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang Y, Chen X, Tian W, Yin X, Wang J and Yang H: The role of TGF-β1-miR-21-ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells. Br J Cancer. 111:772–780. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Donatelli SS, Zhou JM, Gilvary DL, Eksioglu EA, Chen X, Cress WD, Haura EB, Schabath MB, Coppola D, Wei S and Djeu JY: TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells. Proc Natl Acad Sci USA. 111:4203–4208. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Flavell RA, Sanjabi S, Wrzesinski SH and Licona-Limón P: The polarization of immune cells in the tumor environment by TGFbeta. Nat Rev Immunol. 10:554–567. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ikushima H and Miyazono K: TGFbeta signalling: A complex web in cancer progression. Nat Rev Cancer. 10:415–424. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gal A, Sjöblom T, Fedorova L, Imreh S, Beug H and Moustakas A: Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene. 27:1218–1230. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Shintani Y, Okimura A, Sato K, Nakagiri T, Kadota Y, Inoue M, Sawabata N, Minami M, Ikeda N, Kawahara K, et al: Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann Thorac Surg. 92:1794–1804. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Mehta V: Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys. 63:5–24. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kong FM, Pan C, Eisbruch A and Ten Haken RK: Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol. 17:108–120. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Milano MT, Constine LS and Okunieff P: Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol. 17:131–140. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Anscher MS: Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist. 15:350–359. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Anscher MS, Thrasher B, Rabbani Z, Teicher B and Vujaskovic Z: Antitransforming growth factor-beta antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation. Int J Radiat Oncol Biol Phys. 65:876–881. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH and Leof EB: Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest. 114:1308–1316. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Haydont V, Mathé D, Bourgier C, Abdelali J, Aigueperse J, Bourhis J and Vozenin-Brotons MC: Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives. Radiother Oncol. 76:219–225. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Haydont V, Riser BL, Aigueperse J and Vozenin-Brotons MC: Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation: A role for CCN2 and low concentration of TGF-beta1. Am J Physiol Cell Physiol. 294:C1332–C1341. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Rabbani ZN, Anscher MS, Zhang X, Chen L, Samulski TV, Li CY and Vujaskovic Z: Soluble TGFbeta type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats. Int J Radiat Oncol Biol Phys. 57:563–572. 2003. View Article : Google Scholar : PubMed/NCBI |
